COLL
Collegium Pharmaceutical
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: COLL
- PE Ratio
The current PE ratio for Collegium Pharmaceutical stock as of Jun 3, 2026 is 13.16. This is calculated based on the current EPS of $2.36 and the stock price of $31.06 per share. The P/E ratio has a decrease of 36% from the past four quarters average of 20.6.
COLL PE ratio history
The average historical PE ratio of Collegium Pharmaceutical for the last six years is 21.68. The current PE ratio of 13.16 is 39% below the historical average. Over the past six years, COLL's PE ratio was at its highest in the Sep 2023 quarter at 85.96, when the stock price was $22.35 and the EPS was $0.26. The lowest value was in the Sep 2021 quarter, when it reached 6.71 with a price of $19.74 and an EPS of $2.94.
Collegium Pharmaceutical PE ratio by year
Maximum annual increase: 74.61% in 2025
Maximum annual decrease: -64.52% in 2021
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 23.38 | 74.61% | $46.3 | $1.98 |
| 2024 | 13.39 | -37.78% | $28.65 | $2.14 |
| 2023 | 21.52 | N/A | $30.78 | $1.43 |
| 2022 | N/A | N/A | $23.2 | -$0.74 |
| 2021 | 9.11 | -64.52% | $18.68 | $2.05 |
| 2020 | 25.68 | N/A | $20.03 | $0.78 |
| 2019 | N/A | N/A | $20.58 | -$0.68 |
| 2018 | N/A | N/A | $17.17 | -$1.19 |
| 2017 | N/A | N/A | $18.46 | -$2.47 |
| 2016 | N/A | N/A | $15.57 | -$3.88 |
| 2015 | N/A | N/A | $27.5 | -$1.48 |
| 2014 | N/A | N/A | N/A | -$22.72 |
| 2013 | N/A | N/A | N/A | -$4.06 |
Collegium Pharmaceutical PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 14.01 | -40.08% | $33.07 | $2.36 |
| Dec 2025 | 23.38 | 23.64% | $46.3 | $1.98 |
| Sep 2025 | 18.91 | -27.1% | $34.99 | $1.85 |
| Jun 2025 | 25.94 | 18.18% | $29.57 | $1.14 |
| Mar 2025 | 21.95 | 63.93% | $29.85 | $1.36 |
| Dec 2024 | 13.39 | -6.1% | $28.65 | $2.14 |
| Sep 2024 | 14.26 | 34.15% | $38.64 | $2.71 |
| Jun 2024 | 10.63 | -23.03% | $32.2 | $3.03 |
| Mar 2024 | 13.81 | -35.83% | $38.82 | $2.81 |
| Dec 2023 | 21.52 | -74.97% | $30.78 | $1.43 |
| Sep 2023 | 85.96 | N/A | $22.35 | $0.26 |
| Jun 2023 | N/A | N/A | $21.49 | -$0.34 |
| Mar 2023 | N/A | N/A | $23.99 | -$0.87 |
| Dec 2022 | N/A | N/A | $23.2 | -$0.74 |
| Sep 2022 | N/A | N/A | $16.02 | -$1.22 |
COLL Price vs fair value
COLL average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
Currently, COLL's PE ratio is below the 3, 5 and 10-year averages.
PE comparison
With a P/E of 13.16, COLL is below the Healthcare sector and the industry average. Compared to its Healthcare sector average of 23.02, Collegium Pharmaceutical's P/E is 43% lower.
COLL PE vs peers
COLL's PE ratio is lower than its peer stock UTHR.
| Stock name | PE ratio | Market cap |
|---|---|---|
| COLL Collegium Pharmaceutical Inc | 13.88 | $1.06B |
| UTHR UNITED THERAPEUTICS Corp | 18.69 | $23.23B |
| LPCN Lipocine Inc | N/A | $18.05M |
| SUPN Supernus Pharmaceuticals Inc | N/A | $2.59B |
Frequently asked questions
What is Collegium Pharmaceutical's PE ratio?
COLL stock has a price to earnings ratio of 13.16 as of Jun 3, 2026.
What is the 3-year average PE ratio for Collegium Pharmaceutical (COLL)?
The average PE ratio for COLL stock over the past 3 years is 23.98.
What is the 5-year average PE ratio for Collegium Pharmaceutical (COLL)?
The average PE ratio for COLL stock over the past 5 years is 20.28.
What is the highest PE ratio for COLL?
In the last six years, the Sep 2023 quarter recorded the highest quarterly PE ratio at 85.96.
How does the current PE ratio for COLL compare to its historical average?
The current price to earnings ratio of COLL is 39% lower than the 6-year historical average.
How is COLL's PE ratio calculated (Collegium Pharmaceutical PE ratio formula)?
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Jun 3, 2026), Collegium Pharmaceutical's stock price is $31.06. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $2.36. Therefore, Collegium Pharmaceutical's P/E ratio for today is 13.16. PE RATIO(13.16) = STOCK PRICE($31.06) / TTM EPS($2.36)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.